MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent
Go back to MannKind Expands Patent Portfolio With New Clofazimine Formulation Patent| Mannkind Corporation (NASDAQ: MNKD) | Delayed: 4.04 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.04 | 52 Week High | $2.51 | |||
| Open | $4.04 | 52 Week Low | $0.41 | |||
| Day High | $4.04 | P/E | N/A | |||
| Day Low | $4.04 | EPS | $-0.64 | |||
| Volume | 364 | |||||
